🇮🇳 Biocon Ltd
Get Biocon Ltd filings on Telegram the moment they are published.
Follow Biocon Ltd on TelegramOne tap starts your 30-day free trial. No card needed.
Overview: The European Commission granted marketing authorization for Pebrilzo®, a biosimilar pertuzumab for HER2-positive breast cancer, under the EMA's new tailored clinical approach.
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest